Gilead Sciences (GILD) Short Interest Ratio & Short Volume $91.94 -2.17 (-2.31%) (As of 11:03 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Gilead Sciences Short Interest DataGilead Sciences (GILD) has a short interest of 21.98 million shares, representing 1.77% of the float (the number of shares available for trading by the public). This marks a -6.11% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.3, indicating that it would take 3.3 days of the average trading volume of 7.05 million shares to cover all short positions.Current Short Interest21,980,000 sharesPrevious Short Interest23,410,000 sharesChange Vs. Previous Month-6.11%Dollar Volume Sold Short$2.02 billionShort Interest Ratio3.3 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares1,246,266,000 sharesFloat Size1,240,000,000 sharesShort Percent of Float1.77%Today's Trading Volume763,903 sharesAverage Trading Volume7,045,928 sharesToday's Volume Vs. Average11% Short Selling Gilead Sciences? Sign up to receive the latest short interest report for Gilead Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGILD Short Interest Over TimeGILD Days to Cover Over TimeGILD Percentage of Float Shorted Over Time Ad Porter & CompanyViral Trump video releasedPorter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberry reveals what happened during his trip to Mar-a-Lago, his meeting with Donald Trump, and the 10 urgent money moves to make before Jan 20 inauguration. Your link to watch Trump’s Secret Stocks is here. Gilead Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/202421,980,000 shares $2.02 billion -6.1%1.8%3.3 $91.86 11/30/202423,410,000 shares $2.17 billion +29.6%1.9%3.4 $92.58 11/15/202418,060,000 shares $1.60 billion +1.8%1.5%2.7 $88.40 10/31/202417,740,000 shares $1.58 billion +7.7%1.4%2.8 $88.82 10/15/202416,480,000 shares $1.41 billion -7.1%1.3%2.7 $85.82 9/30/202417,740,000 shares $1.49 billion -11.1%1.4%2.7 $83.84 Get the Latest News and Ratings for GILD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter. 9/15/202419,950,000 shares $1.65 billion +0.8%1.6%3 $82.81 8/31/202419,800,000 shares $1.56 billion +18.1%1.6%2.8 $79.00 8/15/202416,770,000 shares $1.25 billion -6.0%1.4%2.3 $74.34 7/31/202417,840,000 shares $1.36 billion -16.1%1.4%2.4 $76.06 7/15/202421,250,000 shares $1.50 billion -7.6%1.7%2.8 $70.81 6/30/202423,000,000 shares $1.58 billion +22.3%1.9%3.1 $68.61 6/15/202418,810,000 shares $1.22 billion -26.0%1.5%2.5 $65.06 5/31/202425,430,000 shares $1.63 billion +17.2%2.1%3.6 $64.27 5/15/202421,700,000 shares $1.45 billion +2.6%1.8%3.2 $67.01 4/30/202421,160,000 shares $1.38 billion -0.1%N/A2.9 $65.20 4/15/202421,180,000 shares $1.43 billion -6.2%N/A2.9 $67.75 3/31/202422,570,000 shares $1.65 billion +17.3%N/A3 $73.25 3/15/202419,250,000 shares $1.42 billion -2.1%1.6%2.7 $73.69 2/29/202419,670,000 shares $1.42 billion -1.1%1.6%2.7 $72.10 2/15/202419,880,000 shares $1.46 billion +27.0%1.6%2.8 $73.37 1/31/202415,660,000 shares $1.23 billion -8.6%1.3%2.2 $78.26 1/15/202417,140,000 shares $1.48 billion +0.6%1.4%2.6 $86.38 12/31/202317,040,000 shares $1.38 billion -7.9%N/A2.7 $81.01 12/15/202318,500,000 shares $1.49 billion +6.2%N/A3 $80.33 11/30/202317,420,000 shares $1.33 billion -3.9%N/A3 $76.60 11/15/202318,130,000 shares $1.36 billion -7.0%N/A3.3 $75.04 10/31/202319,500,000 shares $1.53 billion -4.2%1.6%3.6 $78.54 10/15/202320,350,000 shares $1.58 billion +0.5%1.6%3.9 $77.65 9/30/202320,240,000 shares $1.52 billion +10.4%1.6%3.8 $74.94 9/15/202318,330,000 shares $1.39 billion +0.4%1.5%3.3 $75.67 8/31/202318,250,000 shares $1.40 billion -7.0%1.5%3.2 $76.48 8/15/202319,630,000 shares $1.56 billion +4.2%1.6%3.4 $79.64 7/31/202318,840,000 shares $1.43 billion +7.2%N/A3.3 $76.14 7/15/202317,570,000 shares $1.36 billion +1.3%N/A3 $77.19 6/30/202317,340,000 shares $1.34 billion +6.3%N/A3.2 $77.07 6/15/202316,320,000 shares $1.29 billion +6.8%N/A3 $79.00 5/31/202315,280,000 shares $1.18 billion -15.0%N/A2.7 $76.94 5/15/202317,980,000 shares $1.41 billion -6.7%N/A3.4 $78.38 4/30/202319,280,000 shares $1.59 billion +26.4%N/A3.4 $82.21Elon to SHOCK the Market By Dec. 31st? (Ad)There’s a little-known backdoor way to play Elon’s “Super-IPO”… With as little as $50. Click here to learn all of the details. 4/15/202315,250,000 shares $1.27 billion -1.5%N/A2.6 $83.00 3/31/202315,480,000 shares $1.28 billion +1.8%N/A2.6 $82.97 3/15/202315,200,000 shares $1.21 billion -2.9%N/A2.5 $79.65 2/28/202315,660,000 shares $1.26 billion -0.6%N/A2.3 $80.53 2/15/202315,760,000 shares $1.34 billion +3.9%N/A2.3 $85.05 1/31/202315,170,000 shares $1.27 billion +1.6%N/A2.1 $83.94 1/15/202314,930,000 shares $1.29 billion -8.0%N/A1.9 $86.27 12/30/202216,220,000 shares $1.39 billion +9.9%N/A2.1 $85.85 12/15/202214,760,000 shares $1.28 billion -16.0%N/A1.8 $86.58 11/30/202217,560,000 shares $1.54 billion -15.3%N/A2.1 $87.83 11/15/202220,730,000 shares $1.72 billion +8.7%N/A2.5 $83.00 10/31/202219,070,000 shares $1.50 billion +15.8%N/A2.4 $78.46 10/15/202216,470,000 shares $1.09 billion +0.1%N/A2.3 $66.17 9/30/202216,450,000 shares $1.01 billion -1.4%N/A2.4 $61.69 9/15/202216,690,000 shares $1.08 billion -0.5%N/A2.5 $65.00 8/31/202216,770,000 shares $1.06 billion -1.6%N/A2.5 $63.47 8/15/202217,040,000 shares $1.13 billion +20.3%N/A2.5 $66.21 7/31/202214,160,000 shares $846.06 million -14.5%N/A2 $59.75 7/15/202216,560,000 shares $1.04 billion +13.0%N/A2.2 $62.60 6/30/202214,650,000 shares $905.52 million -6.4%N/A1.9 $61.81 6/15/202215,650,000 shares $913.80 million +6.6%N/A1.9 $58.39 5/31/202214,680,000 shares $952.00 million -12.9%N/A1.7 $64.85 5/15/202216,850,000 shares $1.05 billion +0.9%N/A1.7 $62.37 4/30/202216,700,000 shares $990.98 million +8.7%N/A1.6 $59.34 4/15/202215,370,000 shares $950.17 million +6.3%N/A1.4 $61.82 3/31/202214,460,000 shares $859.65 million -2.6%N/A1.3 $59.45 3/15/202214,840,000 shares $865.47 million -20.3%N/A1.4 $58.32 2/28/202218,630,000 shares $1.13 billion -16.2%N/A1.9 $60.40 2/15/202222,240,000 shares $1.36 billion -7.9%N/A2.3 $61.33 1/31/202224,150,000 shares $1.66 billion +10.4%N/A2.9 $68.68 1/15/202221,880,000 shares $1.57 billion +2.7%N/A0 $71.77 12/31/202121,300,000 shares $1.55 billion -4.1%N/A3 $72.61 12/15/202122,200,000 shares $1.58 billion +1.4%N/A3.2 $71.21 11/30/202121,890,000 shares $1.51 billion -5.3%N/A3.2 $68.93 11/15/202123,120,000 shares $1.55 billion +5.5%N/A3.5 $67.20 10/29/202121,920,000 shares $1.42 billion -8.7%N/A3.4 $64.88 10/15/202124,010,000 shares $1.62 billion -1.1%N/A3.8 $67.63 9/30/202124,280,000 shares $1.70 billion +16.2%N/A3.9 $69.85 9/15/202120,900,000 shares $1.50 billion -6.9%N/A3.4 $71.76 8/31/202122,450,000 shares $1.63 billion -12.7%N/A3.7 $72.78 8/13/202125,700,000 shares $1.83 billion -0.1%N/A4.1 $71.16 7/30/202125,730,000 shares $1.76 billion -5.5%N/A4 $68.29 7/15/202127,220,000 shares $1.86 billion +12.3%N/A4.1 $68.30 6/30/202124,230,000 shares $1.67 billion +0.9%N/A3.5 $68.86 6/15/202124,020,000 shares $1.64 billion +1.4%N/A3.4 $68.09 5/28/202123,690,000 shares $1.57 billion -7.9%N/A3.2 $66.11 5/14/202125,720,000 shares $1.77 billion -10.2%2.1%3.3 $68.91 4/30/202128,640,000 shares $1.83 billion +10.1%2.3%3.7 $63.84 4/15/202126,010,000 shares $1.70 billion +11.0%2.1%3.4 $65.30 3/31/202123,440,000 shares $1.54 billion +4.1%1.9%2.8 $65.50Elon to SHOCK the Market By Dec. 31st? (Ad)There’s a little-known backdoor way to play Elon’s “Super-IPO”… With as little as $50. Click here to learn all of the details. 3/15/202122,520,000 shares $1.39 billion -5.5%1.8%2.4 $61.56 2/26/202123,830,000 shares $1.50 billion +3.1%1.9%2.6 $62.79 2/12/202123,110,000 shares $1.55 billion +7.1%1.9%2.6 $66.92 1/29/202121,580,000 shares $1.40 billion -3.5%1.7%2.3 $64.68 1/15/202122,370,000 shares $1.40 billion +3.7%1.8%2.3 $62.40 12/31/202021,570,000 shares $1.22 billion +22.1%1.7%2.2 $56.65 12/15/202017,670,000 shares $1.06 billion -14.8%1.4%1.9 $59.84 11/30/202020,730,000 shares $1.24 billion -4.5%1.7%2.2 $60.03 11/15/202021,710,000 shares $1.32 billion -4.4%1.7%2.3 $60.59 10/30/202022,700,000 shares $1.33 billion +10.7%1.8%2.4 $58.53 10/15/202020,500,000 shares $1.31 billion +5.9%1.6%2.1 $64.05 9/30/202019,360,000 shares $1.22 billion +7.9%1.6%2.2 $63.19 9/15/202017,950,000 shares $1.19 billion +11.0%1.4%2.1 $66.20 8/31/202016,170,000 shares $1.08 billion -14.1%1.3%1.9 $66.75 8/14/202018,830,000 shares $1.29 billion -11.7%1.5%2 $68.50 7/31/202021,330,000 shares $1.48 billion -3.4%1.7%2.2 $69.53 7/15/202022,090,000 shares $1.69 billion -3.7%1.8%1.7 $76.65 6/30/202022,930,000 shares $1.76 billion -9.1%1.8%1.4 $76.94 6/15/202025,220,000 shares $1.87 billion +4.5%2.0%1.4 $73.97 5/29/202024,140,000 shares $1.88 billion -7.5%1.9%1.1 $77.83 5/15/202026,090,000 shares $1.99 billion +8.2%2.1%1.1 $76.26 4/30/202024,110,000 shares $2.03 billion +6.9%1.9%1 $84.00 4/15/202022,550,000 shares $1.68 billion -4.6%1.8%1 $74.63 3/31/202023,640,000 shares $1.88 billion -11.1%1.9%1.2 $79.64 3/13/202026,584,200 shares $1.95 billion +11.9%2.1%1.1 $73.51 2/28/202023,760,000 shares $1.73 billion +10.2%1.9%1.6 $72.61 2/14/202021,560,000 shares $1.56 billion +4.7%1.7%1.9 $72.34 1/31/202020,590,000 shares $1.54 billion +15.8%1.6%2.2 $74.70 1/15/202017,780,000 shares $1.20 billion -16.5%1.4%2.4 $67.76 12/31/201921,300,000 shares $1.35 billion +32.8%1.7%3.3 $63.15 GILD Short Interest - Frequently Asked Questions What is Gilead Sciences' current short interest? Short interest is the volume of Gilead Sciences shares that have been sold short but have not yet been covered or closed out. As of December 15th, investors have sold 21,980,000 shares of GILD short. 1.77% of Gilead Sciences' shares are currently sold short. Learn More on Gilead Sciences' current short interest. What is a good short interest ratio for Gilead Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GILD shares currently have a short interest ratio of 3.0. Learn More on Gilead Sciences's short interest ratio. Which institutional investors are shorting Gilead Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Gilead Sciences: JPMorgan Chase & Co., Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Parallax Volatility Advisers L.P., Centiva Capital LP, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, Citigroup Inc., Mirae Asset Securities USA Inc., Genus Capital Management Inc., IMC Chicago LLC, Concourse Financial Group Securities Inc., and SG Americas Securities LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Gilead Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.77% of Gilead Sciences' floating shares are currently sold short. Is Gilead Sciences' short interest increasing or decreasing? Gilead Sciences saw a drop in short interest in the month of December. As of December 15th, there was short interest totaling 21,980,000 shares, a drop of 6.1% from the previous total of 23,410,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Gilead Sciences' float size? Gilead Sciences currently has issued a total of 1,246,266,000 shares. Some of Gilead Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Gilead Sciences currently has a public float of 1,240,000,000 shares. How does Gilead Sciences' short interest compare to its competitors? 1.77% of Gilead Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Gilead Sciences: Amgen Inc. (2.15%), Vertex Pharmaceuticals Incorporated (1.37%), Regeneron Pharmaceuticals, Inc. (1.71%), Alnylam Pharmaceuticals, Inc. (2.71%), Biogen Inc. (1.78%), United Therapeutics Co. (5.11%), Neurocrine Biosciences, Inc. (3.35%), Incyte Co. (3.10%), BioMarin Pharmaceutical Inc. (2.73%), Exact Sciences Co. (6.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Gilead Sciences stock? Short selling GILD is an investing strategy that aims to generate trading profit from Gilead Sciences as its price is falling. GILD shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gilead Sciences? A short squeeze for Gilead Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GILD, which in turn drives the price of the stock up even further. How often is Gilead Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GILD, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies AMGN Short Interest VRTX Short Interest REGN Short Interest ALNY Short Interest BIIB Short Interest UTHR Short Interest NBIX Short Interest INCY Short Interest BMRN Short Interest EXAS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GILD) was last updated on 12/30/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredViral Trump video releasedPorter Stansberry’s latest video is going viral… In this bombshell exposé, famed economist Porter Stansberr...Porter & Company | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
